Sevigny Jeffrey 4
4 · Rapport Therapeutics, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Sevigny Jeffrey
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-01+300,000→ 300,000 totalExercise: $9.56Exp: 2035-04-01→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on March 3, 2026, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.